A new anti-cancer drug in the market: Good news for investors or for patients?
Eur J Cancer
.
2008 Sep;44(13):1786-8.
doi: 10.1016/j.ejca.2008.06.021.
Epub 2008 Jul 30.
Authors
Giovanni Apolone
,
Giovanni Tafuri
,
Francesco Trotta
,
Silvio Garattini
PMID:
18672359
DOI:
10.1016/j.ejca.2008.06.021
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Agents / economics*
Drug Approval
Drug Costs
Drug Industry
Humans
Investments
Substances
Antineoplastic Agents